Virus escape from immune control: mechanisms of persistence within the host

Research in Virology - Tập 146 - Trang 267-271 - 1995
M. Paroli1, D. Accapezzato1, V. Barnaba1
1Molecular and Cellular Immunology Laboratory, I Clinica Medica, Università “La Sapienza”, Rome, Italy

Tài liệu tham khảo

Barnaba, 1989, Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection, J. Immunol., 143, 2650, 10.4049/jimmunol.143.8.2650 Barnaba, 1990, Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes, Nature (Lond.), 345, 258, 10.1038/345258a0 Barnaba, 1994, Selective expansion of cytotoxic T lymphocytes with a CD4+ CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus, J. Immunol., 152, 3074, 10.4049/jimmunol.152.6.3074 Bender, 1992, Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge, J. Exp. Med., 175, 1143, 10.1084/jem.175.4.1143 Bertoletti, 1993, Definition of a minimal optimal cytotoxic T cell epitope within the hepatitis B virus nucleocapsid protein, J. Virol., 67, 2376, 10.1128/JVI.67.4.2376-2380.1993 Bertoletti, 1994, Natural variant of cytotoxic epitopes are T-cell receptor antagonists for anti viral cytotoxic T-cells, Nature (Lond.), 369, 407, 10.1038/369407a0 Carma, 1990, Vaccine-induced escape mutant of hepatitis B virus, Lancet, 336, 325, 10.1016/0140-6736(90)91874-A Clerici, 1993, Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals, J Clin. Invest., 91, 759, 10.1172/JCI116294 De Campos-Lima, 1993, HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population, Science, 260, 98, 10.1126/science.7682013 Gajewski, 1991, Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen presenting cell populations, J. Immunol., 146, 1750, 10.4049/jimmunol.146.6.1750 Klenerman, 1994, Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants, Nature (Lond.), 369, 403, 10.1038/369403a0 Lukacher, 1984, In vitro effector function of influenza virus-specific T lymphocyte clones is highly specific, J. Exp. Med., 160, 814, 10.1084/jem.160.3.814 Meyaard, 1993, T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting function?, Immunol. Today, 14, 161, 10.1016/0167-5699(93)90279-T Moskophidis, 1991, Suppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vitro, J. Virol., 66, 3661, 10.1128/JVI.66.6.3661-3668.1992 Moskophidis, 1993, Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells, Nature (Lond.), 362, 758, 10.1038/362758a0 Mosmann, 1989, Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties, Annu. Rev. Immunol., 7, 145, 10.1146/annurev.iy.07.040189.001045 Mueller, 1989, Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell receptor occupancy, Annu. Rev. Immuno., 7, 445, 10.1146/annurev.iy.07.040189.002305 Muller, 1992, Production of hepatitis B virus by stably transfected monocytic cell line U-937: a model for extrahepatic B virus replication, J. Infect. Dis., 165, 929, 10.1093/infdis/165.5.929 Nayersina, 1993, HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection, J. Immunol., 150, 4659, 10.4049/jimmunol.150.10.4659 Nowak, 1991, Antigenic diversity thresholds and the development of AIDS, Science, 354, 963, 10.1126/science.1683006 Phillips, 1991, Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition, Nature (Lond.), 354, 453, 10.1038/354453a0 Pircher, 1990, Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo, Nature (Lond.), 346, 629, 10.1038/346629a0 Schwartz, 1992, Costimualtion of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in IL-2 production and immunotherapy, Cell., 71, 1065, 10.1016/S0092-8674(05)80055-8 Shimizu, 1994, Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses, J. Virol., 68, 1494, 10.1128/JVI.68.3.1494-1500.1994 Snoke, 1993, The inhibition of different T cell lines specific for the same antigen with TCR antagonist peptides, J. Immunol., 151, 6815, 10.4049/jimmunol.151.12.6815 Taniguchi, 1993, A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/Ns1 protein, Virology, 195, 297, 10.1006/viro.1993.1378 Williams, 1990, Costimulation requirements of murine Th1 clones. The role of accessory cell-derived signals in response of anti-CD3 antibodies, J. Immunol., 145, 85, 10.4049/jimmunol.145.1.85